Financial Statements
| Year Ending Dec 2018 (Update) | Year Ending Dec 2017 (Update) | Year Ending Dec 2016 (Restated) | Year Ending Dec 2015 (Update) | |
|---|---|---|---|---|
| Net Sales | 1,015.02 | 993.26 | 992.07 | 882.51 |
| Revenue | 1,015.02 | 993.26 | 992.07 | 882.51 |
| Total Revenue | 1,015.02 | 993.26 | 992.07 | 882.51 |
| Cost of Revenue | 516.45 | 486.80 | 483.90 | 423.13 |
| Cost of Revenue, Total | 516.45 | 486.80 | 483.90 | 423.13 |
| Gross Profit | 498.57 | 506.46 | 508.17 | 459.38 |
| Selling/General/Administrative Expense | 231.60 | 251.86 | 234.59 | 207.31 |
| Labor & Related Expense | 28.47 | 14.79 | 20.07 | 21.83 |
| Selling/General/Administrative Expenses, Total | 260.07 | 266.65 | 254.66 | 229.14 |
| Research & Development | 159.94 | 157.36 | 151.40 | 141.36 |
| Amortization of Intangibles, Operating | 45.29 | 47.34 | 39.56 | 26.51 |
| Depreciation/Amortization | 45.29 | 47.34 | 39.56 | 26.51 |
| Purchased R&D Written-Off | -- | -- | -- | -- |
| Restructuring Charge | 13.58 | 7.56 | 6.73 | 5.73 |
| Impairment-Assets Held for Use | -- | -- | -- | -- |
| Loss (Gain) on Sale of Assets - Operating | -- | -- | -- | 0.00 |
| Unusual Expense (Income) | 13.58 | 7.56 | 6.73 | 5.73 |
| Total Operating Expense | 995.34 | 965.71 | 936.25 | 825.87 |
| Operating Income | 19.69 | 27.55 | 55.82 | 56.64 |
| Interest Expense - Non-Operating | -20.17 | -19.51 | -17.72 | -17.36 |
| Interest Expense, Net Non-Operating | -20.17 | -19.51 | -17.72 | -17.36 |
| Interest Income, Non-Operating | -- | -- | -- | -- |
| Investment Income, Non-Operating | -- | -- | -- | -- |
| Interest/Investment Income, Non-Operating | -- | -- | -- | -- |
| Interest Income (Expense), Net Non-Operating | 1.60 | 4.09 | 0.55 | -1.76 |
| Interest Income (Expense), Net-Non-Operating, Total | -18.57 | -15.42 | -17.17 | -19.12 |
| Gain (Loss) on Sale of Assets | -- | -- | -- | -- |
| Net Income Before Taxes | 1.12 | 12.13 | 38.65 | 37.52 |
| Income Tax – Total | 3.27 | -0.03 | -6.30 | 3.98 |
| Income After Tax | -2.15 | 12.16 | 44.95 | 33.54 |
| Net Income Before Extraordinary Items | -2.15 | 12.16 | 44.95 | 33.54 |
| Extraordinary Item | 1.17 | -27.50 | -- | -- |
| Total Extraordinary Items | 1.17 | -27.50 | -- | -- |
| Net Income | -0.97 | -15.35 | 44.95 | 33.54 |
| Income Available to Common Excluding Extraordinary Items | -2.15 | 12.16 | 44.95 | 33.54 |
| Income Available to Common Stocks Including Extraordinary Items | -0.97 | -15.35 | 44.95 | 33.54 |
| Basic Weighted Average Shares | 44.43 | 46.28 | 46.90 | 47.22 |
| Basic EPS Excluding Extraordinary Items | -0.05 | 0.26 | 0.96 | 0.71 |
| Basic EPS Including Extraordinary Items | -0.02 | -0.33 | 0.96 | 0.71 |
| Dilution Adjustment | -- | -- | -- | -- |
| Diluted Net Income | -0.97 | -15.35 | 44.95 | 33.54 |
| Diluted Weighted Average Shares | 44.43 | 46.28 | 47.80 | 48.15 |
| Diluted EPS Excluding Extraordinary Items | -0.05 | 0.26 | 0.94 | 0.70 |
| Diluted EPS Including Extraordinary Items | -0.02 | -0.33 | 0.94 | 0.70 |
| DPS - Common Stock Primary Issue | -- | -- | -- | -- |
| Gross Dividends - Common Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| (Gain) Loss on Sale of Assets, Supplemental | -- | -- | -- | -- |
| Impairment-Assets Held for Use, Supplemental | 0.50 | 0.90 | 0.00 | -- |
| Litigation Charge, Supplemental | 0.10 | 0.40 | 1.00 | -- |
| Other Unusual Expense (Income), Supplemental | -18.41 | 15.00 | 9.10 | 3.97 |
| Non-Recurring Items, Total | -17.81 | 16.30 | 10.10 | 3.97 |
| Total Special Items | -4.23 | 23.86 | 16.83 | 9.70 |
| Normalized Income Before Taxes | -3.10 | 35.99 | 55.48 | 47.22 |
| Effect of Special Items on Income Taxes | -1.48 | 8.35 | 5.89 | 1.03 |
| Income Taxes Excluding Impact of Special Items | 1.79 | 8.33 | -0.41 | 5.01 |
| Normalized Income After Taxes | -4.89 | 27.67 | 55.89 | 42.21 |
| Normalized Income Available to Common | -4.89 | 27.67 | 55.89 | 42.21 |
| Basic Normalized EPS | -0.11 | 0.60 | 1.19 | 0.89 |
| Diluted Normalized EPS | -0.11 | 0.60 | 1.17 | 0.88 |
| Amortization of Intangibles, Supplemental | 45.29 | 47.34 | 39.56 | 26.51 |
| Depreciation, Supplemental | 20.27 | 18.31 | 15.52 | 13.61 |
| Interest Expense, Supplemental | 20.17 | 19.51 | 17.72 | 17.36 |
| Rental Expense, Supplemental | 8.40 | 8.10 | 8.80 | 8.00 |
| Stock-Based Compensation, Supplemental | 45.28 | 26.53 | 31.83 | 34.07 |
| Advertising Expense, Supplemental | -- | -- | -- | -- |
| Research & Development Expense, Supplemental | 159.94 | 157.36 | 151.40 | 141.36 |
| Audit-Related Fees, Supplemental | 4.89 | 4.81 | -- | 1.79 |
| Audit-Related Fees | 0.94 | 0.79 | -- | 0.66 |
| Tax Fees, Supplemental | 1.99 | 1.48 | -- | 1.45 |
| All Other Fees Paid to Auditor, Supplemental | 0.00 | 0.01 | -- | 0.00 |
| Gross Margin | 49.12 | 50.99 | 51.22 | 52.05 |
| Operating Margin | 1.94 | 2.77 | 5.63 | 6.42 |
| Pretax Margin | 0.11 | 1.22 | 3.90 | 4.25 |
| Effective Tax Rate | 291.35 | -0.21 | -16.30 | 10.61 |
| Net Profit Margin | -0.21 | 1.22 | 4.53 | 3.80 |
| Normalized EBIT | 15.46 | 51.41 | 72.65 | 66.34 |
| Normalized EBITDA | 81.02 | 117.06 | 127.73 | 106.46 |
| Current Tax - Domestic | 0.46 | -10.10 | -7.59 | 3.75 |
| Current Tax - Foreign | 13.86 | 14.75 | 11.72 | 5.80 |
| Current Tax - Local | -0.01 | -2.93 | 0.66 | 1.81 |
| Current Tax - Total | 14.30 | 1.72 | 4.79 | 11.37 |
| Deferred Tax - Domestic | -1.33 | 4.80 | -4.28 | -3.12 |
| Deferred Tax - Foreign | -8.45 | -7.28 | -6.25 | -3.68 |
| Deferred Tax - Local | -1.26 | 0.73 | -0.57 | -0.58 |
| Deferred Tax - Total | -11.04 | -1.75 | -11.09 | -7.38 |
| Other Tax | -- | -- | -- | 0.00 |
| Income Tax - Total | 3.27 | -0.03 | -6.30 | 3.98 |
| Defined Contribution Expense - Domestic | 2.40 | 2.30 | -- | 2.30 |
| Total Pension Expense | 2.40 | 2.30 | -- | 2.30 |
Data provided by Kaleidoscope.